HealthEquity shares are higher today as the market digests the company’s latest fiscal year-end business update, which underscored continued scale gains in HSAs and assets. The company reported 10.6 million HSAs as of January 31, 2026 (up 7% from a year earlier) and total HSA assets of $36.5 billion (up 14%), with HSA investments up 26% year over year—metrics that tend to be closely tied to custodial revenue and long-term earnings power. (ir.healthequity.com)

Beyond top-line account and asset growth, investors are also focusing on the company’s disclosed HSA cash maturity/repricing schedule, which lays out how much cash is expected to reprice over future fiscal years and the associated average yields. That schedule can matter because HealthEquity’s economics are sensitive to the yield earned on custodial HSA cash, and repricing dynamics can change revenue trajectory even without dramatic account growth. (ir.healthequity.com)

Today’s rally also lands against a backdrop of more constructive Street positioning in recent weeks, including higher price targets and an upgrade cycle that has pointed to improving fundamentals and a clearer path to earnings leverage. The most recently cited upgrade in early April helped reset expectations following prior volatility, and investors appear to be leaning into the view that core HSA platform growth and yield mechanics can support upside versus the current share price. (benzinga.com)

Traders will be watching for any incremental updates when management presents at upcoming events and for confirmation that enterprise pipeline strength and retention remain durable. Key swing factors include whether HSA asset growth stays strong, the pace of migration toward higher-value investment balances, and how quickly cash yields evolve as repricing progresses—all of which can move near-term estimates and the stock’s multiple.